Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51

United States Fiscal year ends December CIK 0001819133 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net selling

By person

16 insiders · 29 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Adam Crystal

President, R&D

—

$7.10M (20) scheduled

−$7.10M

115,743

0.0686%

$2.66M

−5.6%

Barbara Weber

Director, Executive Chair

—

$374.29K (2)

−$374.29K

1,629,254

0.9663%

$37.44M

+6.1%

Jessica Newcomb

Principal Accounting Officer

—

$356.27K (5) scheduled

−$356.27K

52,090

0.0309%

$1.20M

−22.6%

Daniella Beckman

Chief Financial Officer

—

$126.53K (2)

−$126.53K

184,297

0.1093%

$4.24M

+39.2%

Third Rock Ventures IV, L.P. entity

10% owner

—

—

—

13,386,574

7.94%

$307.64M

−20.6%

EcoR1 Capital, LLC entity

10% owner

—

—

—

10,630,736

6.30%

$244.31M

−20.3%

Boxer Capital Management, LLC entity

See remarks

—

—

—

3,610,642

2.14%

$82.98M

−46.0%

Malte Peters

President & CEO

—

—

—

367,500

0.2180%

$8.45M

+3,167%

Douglas Barry

General Counsel

—

—

—

66,014

0.0392%

$1.52M

+50.1%

Mace Rothenberg

Director

—

—

—

41,500

0.0246%

$953.74K

+268.9%

Matthew Gall

Chief Financial Officer

—

—

—

40,000

0.0237%

$919.26K

—

John B Ketchum

Director

—

—

—

24,937

0.0148%

$573.09K

+69.8%

Sung Lee

Director

—

—

—

22,870

0.0136%

$525.59K

—

Alexis Borisy

Director

—

—

—

17,500

0.0104%

$402.18K

+55.6%

Lesley Ann Calhoun

Director

—

—

—

16,500

0.0098%

$379.20K

+164.0%

Robert Azelby

Director

—

—

—

5,740

0.0034%

$131.91K

—